EPIRUS FH Reverse Cascade Screening

Status Not yet recruiting

Clinical Trial Summary

Familial hypercholesterolemia (FH) is the most common inherited metabolic disorder resulting in marked elevations in low-density lipoprotein cholesterol (LDL-C). If left untreated, lifelong exposure to elevated LDL-C leads to a substantially increased risk of premature cardiovascular disease as compared to the general population. Although FH adverse cardiovascular outcomes are potentially preventable through early identification of FH individuals and initiation of effective treatment, available evidence shows that FH is under-diagnosed and under-treated. Childhood is the optimal period for FH screening, because due to minimal dietary and hormonal influences, LDL-C levels reflect predominantly the genetic component in children and are well suited to discriminate FH from other causes of elevated LDL-C. If FH remains untreated in this latent stage of the disease, individuals show a 10-fold increase of cardiovascular risk during early and middle adulthood. In this context, an effective approach for detecting FH would be a screening during childhood or in young adolescents in combination with reverse cascade screening of first-degree relatives of FH individuals. EPIRUS-FH registry is a model program of reverse cascade screening for FH in children and adolescents in Northwest Greece that aims to increase public and physician awareness, strengthen the national registry of familial hypercholesterolemia (HELLAS-FH) and constitute the core for a national FH registry in children and adolescents in Greece.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05825612
Study type	Observational [Patient Registry]
Source	Hellenic Atherosclerosis Society
Contact	Haralampos Milionis
Phone	+302651099736
Email	hmilioni@uoi.gr
Status	Not yet recruiting
Phase
Start date	May 2023
Completion date	May 2033

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05284513` - Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)	N/A
Enrolling by invitation	`NCT05271305` - Pilot Study for a National Screening for Familial Hypercholesterolemia
Completed	`NCT02750527` - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Not yet recruiting	`NCT00924339` - Soy Food Intervention Trial	N/A
Withdrawn	`NCT00751608` - Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients	Phase 2
Terminated	`NCT00079846` - Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy	Phase 2
Completed	`NCT02624869` - Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)	Phase 3
Recruiting	`NCT05758779` - The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial	N/A
Enrolling by invitation	`NCT04929457` - Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
Not yet recruiting	`NCT04455581` - A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia	Phase 2
Recruiting	`NCT04101149` - Genetic Causes of Familial Hypercholesterolemia
Completed	`NCT00943306` - Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia	Phase 3
Completed	`NCT02462655` - Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia	N/A
Terminated	`NCT00079859` - Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy	Phase 2
Recruiting	`NCT05066932` - Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia
Not yet recruiting	`NCT04958629` - A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
Completed	`NCT02709850` - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia	Phase 1
Active, not recruiting	`NCT03832985` - Pediatric Reporting of Adult-Onset Genomic Results	Early Phase 1
Terminated	`NCT02013713` - French Observatory of Familial Hypercholesterolemia in Cardiology
Recruiting	`NCT02009345` - Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada